Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;391(2):125-39.
doi: 10.1007/BF00437591.

Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study

Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study

W Schürch et al. Virchows Arch A Pathol Anat Histol. 1981.

Abstract

A series of 23 primary invasive and 7 metastatic carcinomas was examined by light microscopy (LM), transmission electron microscopy (TEM) and immunofluorescence (IF), the latter employing an anti-actin antibody. The results were correlated with macroscopic features such as retraction and consistency. Stromal cells rich in actin, readily identified by IF in firm and retracted carcinomas, were rare or absent in neoplasms lacking these features. TEM established the myofibroblastic nature of these stromal cells. Alternate sections (LM, IF) of each neoplasm demonstrated that myofibroblasts were more numerous in "young" mesenchymal stroma than in densely sclerotic areas. The connective tissue adjacent to intraductal mammary carcinoma lacked myofibroblasts, suggesting that epithelial stromal invasion is required to evoke a myofibroblastic stromal response. Myofibroblasts which possess synthetic (type III collagen) and contractile properties may well contribute to the firm consistency and retraction which characterize many carcinomas. The induction of myofibroblasts might represent an important host stromal response directed toward containment of invasive and/or metastatic carcinoma. This response may be especially important in neoplasms with weak antigenicity and/or slow doubling times.

PubMed Disclaimer

References

    1. Surg Gynecol Obstet. 1977 Sep;145(3):389-94 - PubMed
    1. Am J Pathol. 1973 Sep;72(3):473-88 - PubMed
    1. Int Rev Exp Pathol. 1976;16:207-48 - PubMed
    1. Ann Intern Med. 1975 Jan;82(1):96-100 - PubMed
    1. Cancer. 1970 Mar;25(3):586-600 - PubMed

LinkOut - more resources